drug

Prescription-drug prices have been outpacing the growth in prices for other medical products and services, according to a study from the Government Accountability Office this week. Which drugs have seen the biggest hikes?

The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.

In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.

Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis. Here's why the move could prove an ill-needed distraction for the electronics giant.

When Merck halted a late-stage study of its potential clot-preventing drug vorapaxar in stroke victims last week, it didn't explain why. Now, the company has confirmed it stopped the study after concerns that the drug increased the risk of bleeding in some patients.

As costs rise for tuition, books and dorm-living, you'd think students would want to spend less on everything else. Think again. According to a 2010 report, the nearly 16 million college students who fill campuses this academic year will each drop about $361 more than last year in discretionary...

Just days after Johnson & Johnson's Children's Tylenol started returning to store shelves, the health care giant has recalled about four million packages of Children's Benadryl allergy tablets and some 800,000 bottles of Junior Strength Motrin, citing manufacturing problems.

Drug-makers Amgen and Johnson & Johnson are voluntarily recalling two brands of an injectable anemia medication because of the possibility that vials of it may also contain tiny glass flakes. The drug, Epoetin alfa, is marketed under the brand names Epogen and Procrit.

Drugmaker Bristol-Myers Squibb plans to buy ZymoGenetics, its partner in developing a hepatitis C treatment, for $885 million. The move is part of a trend of pharmaceutical acquisitions as several big patents face expiration soon.

Two federal agencies are investigating whether drugmaker Merck & Co. violated the Foreign Corrupt Practices Act, which bars U.S. companies from bribing foreign officials.